Dr. Nakhle Saba
Claim this profileTulane Cancer Center
Studies Lymphoma
Studies Mantle Cell Lymphoma
14 reported clinical trials
28 drugs studied
Area of expertise
1Lymphoma
MYC positive
CD30 negative
HTLV-1 positive
2Mantle Cell Lymphoma
CCND1 positive
t(11;14) positive
Affiliated Hospitals
Clinical Trials Nakhle Saba is currently running
Digital Tomosynthesis vs. Standard Mammography
for Breast Cancer Screening
This randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer. Screening for breast cancer with tomosynthesis mammography may be superior to digital mammography for breast cancer screening and may help reduce the need for additional imaging or treatment.
Recruiting2 awards Phase 34 criteria
DPX-Survivac + Pembrolizumab
for Lymphoma
This is a Phase 2b, randomized, open label study to assess the safety and efficacy of DPX-Survivac and pembrolizumab, with and without low-dose cyclophosphamide (CPA) in subjects with relapsed or refractory DLBCL.
Recruiting1 award Phase 2
More about Nakhle Saba
Clinical Trial Related4 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Nakhle Saba has experience with
- Brentuximab Vedotin
- Cyclophosphamide
- LOXO-305
- Rituximab
- Dexamethasone
- Doxorubicin
Breakdown of trials Nakhle Saba has run
Lymphoma
- A Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma
- Pirtobrutinib vs Ibrutinib for Chronic Lymphocytic Leukemia
- realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL
Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia
B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nakhle Saba specialize in?
Nakhle Saba focuses on Lymphoma and Mantle Cell Lymphoma. In particular, much of their work with Lymphoma has involved MYC positive patients, or patients who are CD30 negative.
Is Nakhle Saba currently recruiting for clinical trials?
Yes, Nakhle Saba is currently recruiting for 5 clinical trials in New Orleans Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Nakhle Saba has studied deeply?
Yes, Nakhle Saba has studied treatments such as Brentuximab Vedotin, Cyclophosphamide, LOXO-305.
What is the best way to schedule an appointment with Nakhle Saba?
Apply for one of the trials that Nakhle Saba is conducting.
What is the office address of Nakhle Saba?
The office of Nakhle Saba is located at: Tulane Cancer Center, New Orleans, Louisiana 70112 United States. This is the address for their practice at the Tulane Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.